Future of immunotherapy for colorectal cancer

Abstract

John Marshall speaks to Ruth Williamson, Commissioning Editor: John Marshall is a global leader in the research and development of drugs for colon cancer and other gastrointestinal cancers. He is the clinical director of oncology for Georgetown University Hospital (Washington, DC, USA), associate director for clinical care of the Lombardi Comprehensive Cancer Center (Washington, DC, USA) and chief of the Division of Hematology-Oncology, Georgetown University Hospital. He is widely published in the field of clinical oncology, and is the principal investigator of over 150 clinical trials, at both local and national levels. In 2009, Marshall became the founding director of the Otto J Ruesch Center for the Cure of Gastrointestinal Cancer (Washington, DC, USA) and for over a decade he has directed Lombardi’s Developmental Therapeutics Program, while also maintaining his regular clinical practice. His own research focuses on the development of a novel vaccine for the treatment of advanced colon cancer.